{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:19:00Z","timestamp":1773289140244,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ejphar.2006.07.016","type":"journal-article","created":{"date-parts":[[2006,7,24]],"date-time":"2006-07-24T13:09:36Z","timestamp":1153746576000},"page":"165-173","source":"Crossref","is-referenced-by-count":35,"title":["The cannabinoid agonist WIN 55,212-2 inhibits TNF-\u03b1-induced neutrophil transmigration across ECV304 cells"],"prefix":"10.1016","volume":"547","author":[{"given":"Olov","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig O.P.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.07.016_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2006.07.016_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(03)00381-8","article-title":"The therapeutic potential of cannabis","volume":"l2","author":"Baker","year":"2003","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2006.07.016_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/0264-6021:3600067","article-title":"Cannabinoid-receptor-independent cell signalling by N-acylethanolamines","volume":"360","author":"Berdyshev","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2006.07.016_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1046\/j.1471-4159.2003.02244.x","article-title":"Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?","volume":"88","author":"Berger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2006.07.016_bib6","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.4049\/jimmunol.165.12.7180","article-title":"Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase","volume":"165","author":"Bowie","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/labinvest.3780006","article-title":"Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24\/83","volume":"80","author":"Brown","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2006.07.016_bib8","series-title":"2005 Symposium on the Cannabinoids","first-page":"16","article-title":"Molecular identification of GPR55 as a third G protein-coupled receptor responsive to cannabinoid ligands","author":"Brown","year":"2005"},{"key":"10.1016\/j.ejphar.2006.07.016_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjp.0704466","article-title":"Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat","volume":"135","author":"Conti","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib10","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/01.STR.22.10.1276","article-title":"Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons","volume":"22","author":"del Zoppo","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2006.07.016_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-5728(03)00259-5","article-title":"No evidence for direct modulatory effects of delta 9-tetrahydrocannabinol on human polymorphonuclear leukocytes","volume":"141","author":"Deusch","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.0703303","article-title":"Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia\u2013reperfusion injury: involvement of cytokine\/chemokines and PMN","volume":"75","author":"Di Filippo","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nat. Rev., Drug Discov."},{"key":"10.1016\/j.ejphar.2006.07.016_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2006.07.016_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0006-2952(99)00342-1","article-title":"Inhibition of interleukin-8-activated human neutrophil chemotaxis by thapsigargin in a calcium and cyclic AMP-dependent way","volume":"59","author":"Elferink","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/glia.10177","article-title":"Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide","volume":"41","author":"Facchinetti","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2006.07.016_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannbinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejphar.2006.07.016_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(01)00287-1","article-title":"Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus","volume":"106","author":"Hajos","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2006.07.016_bib19","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0024-3205(98)00139-8","article-title":"Ibuprofen inhibits leukocyte migration through endothelial cell monolayers","volume":"62","author":"Hofbauer","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2006.07.016_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","article-title":"The cannabinoid receptors","volume":"68\u201369","author":"Howlett","year":"2002","journal-title":"Prostaglandins other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2006.07.016_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology, XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2006.07.016_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-8993(98)00634-9","article-title":"Decreased endothelial cell glutathione and increased sensitivity to oxidative stress in an in vitro blood-brain barrier model system","volume":"802","author":"Hurst","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.07.016_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(02)02698-5","article-title":"Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids","volume":"458","author":"Ihenetu","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s004410051340","article-title":"Cell\u2013cell contacts in the human cell line ECV304 exhibit both endothelial and epithelial characteristics","volume":"297","author":"Kiessling","year":"1999","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2006.07.016_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.intimp.2004.09.027","article-title":"Inhibitory effect of luteolin on TNF-alpha-induced IL-8 production in human colon epithelial cells","volume":"5","author":"Kim","year":"2005","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4049\/jimmunol.148.1.72","article-title":"Neutrophil migration across monolayers of resting or cytokine-activated endothelial cells. Role of intracellular calcium changes and fusion of specific granules with the plasma membrane","volume":"148","author":"Kuijpers","year":"1992","journal-title":"J. Immunol."},{"issue":"Pt 3","key":"10.1016\/j.ejphar.2006.07.016_bib28","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/0264-6021:3460835","article-title":"Functional CB1 cannabinoid receptors in human vascular endothelial cells","volume":"346","author":"Liu","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2006.07.016_bib29","unstructured":"McHugh, D., Ross, R. A., 2004. Anandamide and cannabidiol potently inhibit human neutrophil migration. Proceedings of the British Pharmacological Society at http:\/\/www.pa2online.org\/Vol1Issue1abst001P.html."},{"key":"10.1016\/j.ejphar.2006.07.016_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuroscience.2004.08.044","article-title":"Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia","volume":"129","author":"Muthian","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2006.07.016_bib31","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1523\/JNEUROSCI.19-08-02987.1999","article-title":"Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures","volume":"19","author":"Nagayama","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.07.016_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004647-199702000-00013","article-title":"Inhibition of tumor necrosis factor and amelioration of brain infarction in mice","volume":"17","author":"Nawashiro","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2006.07.016_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00210-003-0831-3","article-title":"CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes","volume":"368","author":"Nieri","year":"2003","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2006.03.021","article-title":"Suppression by WIN 55,212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol","volume":"538","author":"Oka","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2003.08.003","article-title":"Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions","volume":"46","author":"Pistis","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2006.07.016_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bjp.0705778","article-title":"Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons","volume":"142","author":"Price","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib37","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awg224","article-title":"Cannabinoids inhibit neurodegeneration in models of multiple sclerosis","volume":"126","author":"Pryce","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2006.07.016_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.0.CO;2-W","article-title":"Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells","volume":"29","author":"Puffenbarger","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2006.07.016_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.brainresrev.2004.06.006","article-title":"Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease","volume":"46","author":"Raivich","year":"2004","journal-title":"Brain Res., Brain Res. Rev."},{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2006.07.016_bib40","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1086\/344266","article-title":"The chemokine system in neuroinflammation: an update","volume":"186","author":"Ransohoff","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2006.07.016_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1460-9568.1999.00480.x","article-title":"Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes","volume":"11","author":"Sagan","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.07.016_bib42","series-title":"2005 Symposium on the Cannabinoids","first-page":"106","article-title":"A new receptor for cannabinoid ligands","author":"Sj\u00f6gren","year":"2005"},{"key":"10.1016\/j.ejphar.2006.07.016_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(01)01477-7","article-title":"The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models","volume":"432","author":"Smith","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(01)01142-6","article-title":"Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands","volume":"425","author":"Smith","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuint.2003.08.009","article-title":"Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex-involvement of Na(+)\/K(+)-ATPase","volume":"44","author":"Steffens","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2006.07.016_bib46","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.4049\/jimmunol.171.11.6097","article-title":"Activation of endothelial extracellular signal-regulated kinase is essential for neutrophil transmigration: potential involvement of a soluble neutrophil factor in endothelial activation","volume":"171","author":"Stein","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02624456","article-title":"Spontaneous transformation and immortalization of human endothelial cells","volume":"26","author":"Takahashi","year":"1990","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"10.1016\/j.ejphar.2006.07.016_bib48","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00001756-200105250-00008","article-title":"A comparison of the induction of immortalized endothelial cell impermeability by astrocytes","volume":"12","author":"Tan","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.ejphar.2006.07.016_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.HYP.33.1.429","article-title":"Mesenteric vasodilation mediated by endothelial anandamide receptors","volume":"33","author":"Wagner","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2006.07.016_bib50","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1523\/JNEUROSCI.21-17-06475.2001","article-title":"Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity","volume":"21","author":"van der Stelt","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.07.016_bib51","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1073\/pnas.84.24.9233","article-title":"Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines","volume":"84","author":"Yoshimura","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.07.016_bib52","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/WNL.44.9.1747","article-title":"Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat","volume":"44","author":"Zhang","year":"1994","journal-title":"Neurology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906007631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906007631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:45:20Z","timestamp":1683524720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299906007631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":51,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0014299906007631"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.07.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}